Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan-R Targan

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
American Journal of Human Genetics|February 11, 2003
A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi JewsKazuhito Sugimura, Kent D Taylor, Ying-chao Lin, et al.
Gastroenterology|April 13, 2017
Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's DiseaseRivkah Gonsky, Phillip Fleshner, Richard L Deem, et al.
Diseases of the Colon and Rectum|December 19, 2007
Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitisGil Y Melmed, Phillip R Fleshner, Ovunc Bardakcioglu, et al.
Gastroenterology|April 19, 2006
Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's diseaseLing Mei, Stephan R Targan, Carol J Landers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or UstekinumabAndres J Yarur, Dermot McGovern, Maria T Abreu, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
Journal of Digestive Diseases|December 19, 2017
Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel diseasePhillip Gu, Anshika Kapur, Dalin Li, et al.
The American Journal of Surgical Pathology|August 19, 2004
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel diseaseStephen A Geller, Marla C Dubinsky, F Fred Poordad, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 26, 2018
Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel DiseaseVineet S Rolston, Anish V Patel, Thomas J Learch, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
American Journal of Human Genetics|February 11, 2003
A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi JewsKazuhito Sugimura, Kent D Taylor, Ying-chao Lin, et al.
Gastroenterology|April 13, 2017
Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's DiseaseRivkah Gonsky, Phillip Fleshner, Richard L Deem, et al.
Diseases of the Colon and Rectum|December 19, 2007
Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitisGil Y Melmed, Phillip R Fleshner, Ovunc Bardakcioglu, et al.
Gastroenterology|April 19, 2006
Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's diseaseLing Mei, Stephan R Targan, Carol J Landers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or UstekinumabAndres J Yarur, Dermot McGovern, Maria T Abreu, et al.
The American Journal of Gastroenterology|July 5, 2006
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnessesGil Y Melmed, Andrew F Ippoliti, Konstantinos A Papadakis, et al.
Journal of Digestive Diseases|December 19, 2017
Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel diseasePhillip Gu, Anshika Kapur, Dalin Li, et al.
The American Journal of Surgical Pathology|August 19, 2004
Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel diseaseStephen A Geller, Marla C Dubinsky, F Fred Poordad, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 26, 2018
Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel DiseaseVineet S Rolston, Anish V Patel, Thomas J Learch, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
Pageof 19